Cargando…
Association of CYP2C19 Polymorphisms with the Clinical Efficacy of Clopidogrel Therapy in Patients Undergoing Carotid Artery Stenting in Asia
The CYP2C19 gene plays a detrimental role in the metabolism of clopidogrel. This study aimed to investigate the association between CYP2C19 polymorphisms and the clinical efficacy of clopidogrel therapy in patients who have undergone carotid artery stenting (CAS). CYP2C19 genotype screening was perf...
Autores principales: | Zhu, Wen-Yao, Zhao, Ting, Xiong, Xiao-Yi, Li, Jie, Wang, Li, Zhou, Yu, Gong, Zi-Li, Cheng, Sai-Yu, Liu, Yong, Shuai, Jie, Yang, Qing-Wu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853775/ https://www.ncbi.nlm.nih.gov/pubmed/27137706 http://dx.doi.org/10.1038/srep25478 |
Ejemplares similares
-
Clinical importance of testing for clopidogrel resistance in patients undergoing carotid artery stenting—a systematic review
por: Collette, Sabine L., et al.
Publicado: (2021) -
Comparison of Clopidogrel and Ticlopidine/Ginkgo Biloba in Patients With Clopidogrel Resistance and Carotid Stenting
por: Chung, Jong-Won, et al.
Publicado: (2019) -
Revascularization of acute stent thrombosis caused by diarrhea after carotid artery stenting in an intermediate clopidogrel metabolizer
por: Wang, Huaishun, et al.
Publicado: (2023) -
Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients
por: Zhuo, Zhong-ling, et al.
Publicado: (2018) -
Association with CYP2C19 polymorphisms and Clopidogrel in treatment of elderly stroke patients
por: Li, Changqing, et al.
Publicado: (2021)